Discovery of 2,6-disubstituted pyrazine derivatives as inhibitors of CK2 and PIM kinases

Gingipalli, Lakshmaiah; Block, Michael H.; Bao, Larry; Cooke, Emma; Dakin, Les A.; Denz, Christopher R.; Ferguson, Andrew D.; Johannes, Jeffrey W.; Larsen, Nicholas A.; Lyne, Paul D.; Pontz, Timothy W.; Wang, Tao; Wu, Xiaoyun; Wu, Allan; Zhang, Hai-Jun; Zheng, Xiaolan; Dowling, James E.; Lamb, Michelle L.

doi:10.1016/j.bmcl.2018.03.018

Discovery of 2,6-disubstituted pyrazine derivatives as inhibitors of CK2 and PIM kinases

Journal Article · Tue May 01 00:00:00 EDT 2018 · Bioorg. Med. Chem. Lett.

DOI:https://doi.org/10.1016/j.bmcl.2018.03.018· OSTI ID:1847692

Gingipalli, Lakshmaiah; Block, Michael H.; Bao, Larry; Cooke, Emma; Dakin, Les A.; Denz, Christopher R.; Ferguson, Andrew D.; Johannes, Jeffrey W.; Larsen, Nicholas A.; Lyne, Paul D.; Pontz, Timothy W.; Wang, Tao; Wu, Xiaoyun; Wu, Allan; Zhang, Hai-Jun; Zheng, Xiaolan; Dowling, James E.; Lamb, Michelle L.

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; INDUSTRY

OSTI ID:: 1847692

Journal Information:: Bioorg. Med. Chem. Lett., Journal Name: Bioorg. Med. Chem. Lett. Journal Issue: (8) Vol. 28

Country of Publication:: United States

Language:: ENGLISH

References (30)

Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells Pierre, Fabrice; Regan, Collin F.; Chevrel, Marie-Claire Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 9 https://doi.org/10.1016/j.bmcl.2012.02.099	journal	May 2012
Protein kinase CK2 – A key suppressor of apoptosis Ahmad, Kashif A.; Wang, Guixia; Unger, Gretchen Advances in Enzyme Regulation, Vol. 48, Issue 1 https://doi.org/10.1016/j.advenzreg.2008.04.002	journal	January 2008
Identification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2: A Successful Example of a Virtual Screening Application Cozza, Giorgio; Bonvini, Paolo; Zorzi, Elisa Journal of Medicinal Chemistry, Vol. 49, Issue 8 https://doi.org/10.1021/jm060112m	journal	March 2006
CK2 Inhibits Apoptosis and Changes Its Cellular Localization Following Ionizing Radiation Yamane, Kazuhiko; Kinsella, Timothy J. Cancer Research, Vol. 65, Issue 10 https://doi.org/10.1158/0008-5472.CAN-04-3941	journal	May 2005
Protein kinase CK2: structure, regulation and role in cellular decisions of life and death Litchfield, David W. Biochemical Journal, Vol. 369, Issue 1 https://doi.org/10.1042/bj20021469	journal	January 2003
CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy Siddiqui-Jain, Adam; Drygin, Denis; Streiner, Nicole Cancer Research, Vol. 70, Issue 24 https://doi.org/10.1158/0008-5472.CAN-10-1893	journal	December 2010
Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization Dowling, James E.; Chuaqui, Claudio; Pontz, Timothy W. ACS Medicinal Chemistry Letters, Vol. 3, Issue 4 https://doi.org/10.1021/ml200257n	journal	February 2012
Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2 Nie, Zhe; Perretta, Carin; Erickson, Philip Bioorganic & Medicinal Chemistry Letters, Vol. 17, Issue 15 https://doi.org/10.1016/j.bmcl.2007.05.041	journal	August 2007
Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: Evaluation of their effects on cells and different molecular forms of human CK2 Zien, Piotr; Duncan, James S.; Skierski, Janusz Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Vol. 1754, Issue 1-2 https://doi.org/10.1016/j.bbapap.2005.07.039	journal	December 2005
Multiple myeloma cell survival relies on high activity of protein kinase CK2 Piazza, Francesco A.; Ruzzene, Maria; Gurrieri, Carmela Blood, Vol. 108, Issue 5 https://doi.org/10.1182/blood-2005-11-013672	journal	September 2006
Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor Haddach, Mustapha; Michaux, Jerome; Schwaebe, Michael K. ACS Medicinal Chemistry Letters, Vol. 3, Issue 2 https://doi.org/10.1021/ml200259q	journal	December 2011
7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of Pim kinase inhibitors with potent cell antiproliferative activity Pierre, Fabrice; Stefan, Eric; Nédellec, Anne-Sophie Bioorganic & Medicinal Chemistry Letters, Vol. 21, Issue 22 https://doi.org/10.1016/j.bmcl.2011.09.059	journal	November 2011
Structure-Activity Relationships of Pyrazine-Based CK2 Inhibitors: Synthesis and Evaluation of 2,6-Disubstituted Pyrazines and 4,6-Disubstituted Pyrimidines Suzuki, Yamato; Cluzeau, Jérôme; Hara, Takafumi Archiv der Pharmazie, Vol. 341, Issue 9 https://doi.org/10.1002/ardp.200700269	journal	September 2008
Discovery and structure–activity relationship of 2,6-disubstituted pyrazines, potent and selective inhibitors of protein kinase CK2 Fuchi, Nobuhiro; Iura, Yosuke; Kaneko, Hiroaki Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 13 https://doi.org/10.1016/j.bmcl.2012.05.006	journal	July 2012
Development and exploitation of CK2 inhibitors Sarno, Stefania; Ruzzene, Maria; Frascella, Pietrogiulio Molecular and Cellular Biochemistry, Vol. 274, Issue 1-2 https://doi.org/10.1007/s11010-005-3079-z	journal	June 2005
Profiling of Protein Kinases in the Neoplastic Transformation of Human Ovarian Surface Epithelium Wong, Alice S. T.; Kim, Sung O.; Leung, Peter C. K. Gynecologic Oncology, Vol. 82, Issue 2 https://doi.org/10.1006/gyno.2001.6280	journal	August 2001
Features and potentials of ATP-site directed CK2 inhibitors Sarno, Stefania; Salvi, Mauro; Battistutta, Roberto Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Vol. 1754, Issue 1-2 https://doi.org/10.1016/j.bbapap.2005.07.043	journal	December 2005
Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo Dowling, James E.; Alimzhanov, Marat; Bao, Larry ACS Medicinal Chemistry Letters, Vol. 7, Issue 3 https://doi.org/10.1021/acsmedchemlett.5b00452	journal	January 2016
Discovery of a Potent and Selective Protein Kinase CK2 Inhibitor by High-Throughput Docking Vangrevelinghe, Eric; Zimmermann, Kaspar; Schoepfer, Joseph Journal of Medicinal Chemistry, Vol. 46, Issue 13 https://doi.org/10.1021/jm030827e	journal	May 2003
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia Keeton, Erika K.; McEachern, Kristen; Dillman, Keith S. Blood, Vol. 123, Issue 6 https://doi.org/10.1182/blood-2013-04-495366	journal	February 2014
Coumarin as Attractive Casein Kinase 2 (CK2) Inhibitor Scaffold: An Integrate Approach To Elucidate the Putative Binding Motif and Explain Structure–Activity Relationships Chilin, Adriana; Battistutta, Roberto; Bortolato, Andrea Journal of Medicinal Chemistry, Vol. 51, Issue 4 https://doi.org/10.1021/jm070909t	journal	February 2008
Casein Kinase 2 Is Activated and Essential for Wnt/β-Catenin Signaling Gao, Yuan; Wang, Hsien-yu Journal of Biological Chemistry, Vol. 281, Issue 27 https://doi.org/10.1074/jbc.M601112200	journal	July 2006
Protein kinase CK2 phosphorylates and upregulates Akt/PKB Di Maira, G.; Salvi, M.; Arrigoni, G. Cell Death & Differentiation, Vol. 12, Issue 6 https://doi.org/10.1038/sj.cdd.4401604	journal	April 2005
Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases Dakin, Les A.; Block, Michael H.; Chen, Huawei Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 14 https://doi.org/10.1016/j.bmcl.2012.05.098	journal	July 2012
CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response Kato, Tomohisa; Delhase, Mireille; Hoffmann, Alexander Molecular Cell, Vol. 12, Issue 4 https://doi.org/10.1016/S1097-2765(03)00358-7	journal	October 2003
The Protein Kinase CK2 Phosphorylates SNAP190 to Negatively Regulate SNAPC DNA Binding and Human U6 Transcription by RNA Polymerase III Gu, Liping; Husain-Ponnampalam, Rhonda; Hoffmann-Benning, Susanne Journal of Biological Chemistry, Vol. 282, Issue 38 https://doi.org/10.1074/jbc.M702269200	journal	September 2007
Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo Dowling, James E.; Alimzhanov, Marat; Bao, Larry ACS Medicinal Chemistry Letters, Vol. 4, Issue 8 https://doi.org/10.1021/ml400197u	journal	July 2013
ATP Site-Directed Inhibitors of Protein Kinase CK2: An Update Sarno, S.; Papinutto, E.; Franchin, C. Current Topics in Medicinal Chemistry, Vol. 11, Issue 11 https://doi.org/10.2174/156802611795589638	journal	June 2011
Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth Zhu, Dan; Hensel, Jennifer; Hilgraf, Robert Molecular and Cellular Biochemistry, Vol. 333, Issue 1-2 https://doi.org/10.1007/s11010-009-0216-0	journal	July 2009
Inspecting the Structure-Activity Relationship of Protein Kinase CK2 Inhibitors Derived from Tetrabromo-Benzimidazole Battistutta, Roberto; Mazzorana, Marco; Sarno, Stefania Chemistry & Biology, Vol. 12, Issue 11 https://doi.org/10.1016/j.chembiol.2005.08.015	journal	November 2005

Similar Records

Discovery of 2,6-disubstituted pyrazine derivatives as inhibitors of CK2 and PIM kinases

Journal Article · Tue May 01 00:00:00 EDT 2018 · Bioorg. Med. Chem. Lett. · OSTI ID:1845470

The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors

Journal Article · Sat Jan 31 23:00:00 EST 2015 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1498382

Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors

Journal Article · Sun Dec 27 23:00:00 EST 2015 · ACS Medicinal Chemistry Letters · OSTI ID:1438892

Discovery of 2,6-disubstituted pyrazine derivatives as inhibitors of CK2 and PIM kinases

Citation Formats

References (30)

Similar Records

Related Subjects